As per Roots Analysis, the global specialty CROs market valued at USD 1.2 billion in the current year is anticipated to grow at a lucrative CAGR of 8.6% during the forecast period.
The market sizing and opportunity analysis has been segmented across the following parameters:
Target Therapeutic Area
Oncological Disorders
Metabolic Disorders
Cardiovascular Disorders
Diabetes
Others
Type of Service
Preclinical Services
Clinical Services
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World
SPECIALTY CROS MARKET: GROWTH AND TRENDS
Over the years, the biopharmaceutical industry has undergone a major transformation in its approach towards R&D outsourcing. Specialty contract research organizations (CROs) have become prominent players, addressing limitations often faced with traditional, full-service CROs. While full-service providers offer a broad range of capabilities, they frequently struggle to tailor their services to the specific needs of small-scale biotech companies and start-ups. In contrast, specialty CROs focus on niche segments, delivering expertise in targeted clinical or preclinical services, while concentrating on a particular disease area such as oncology, heart diseases, metabolic disorders, and central nervous system (CNS) conditions. Services commonly outsourced to these organizations include pharmacovigilance, target evaluation, formulation development, cell line development, data management, project management, biostatistics and others. Further, specialty CROs are also increasingly adopting strategic models to broaden their service offerings and expand geographically, aiming to better serve the evolving needs of the global biopharmaceutical sector.
SPECIALTY CROS MARKET: KEY INSIGHTS
The report delves into the current state of the global specialty CROs market and identifies potential growth opportunities within industry. Some key findings from the report include:
The wealth of services offered by CROs have made them an indispensable platform for drug development.
Over 200 speciality CROs were identified after detailed due diligence of more than 1,000 CROs based on the specific capabilities and the range of services they provide.
With 26% of the organizations specializing in preclinical services, the service portfolio of these CROs caters to a wide array of client requirements.
Toxicology and pharmacology are the most popular preclinical services, with ~14% of the CROs offering the services related to toxicology and pharmacology in their respective portfolios.
Nearly 32 companies specialize in test models and medical imaging / biomarker-based analysis.
Over 40% of the speciality CROs offered biostatistics related services, followed by speciality CROs offering clinical monitoring and project management services.
Notably, medical writing and regulatory management / submission is also frequently outsourced.
Though the overall market is dominated by a handful of bigger CROs, the market within the speciality CRO segment is highly fragmented; US continues to remain the primary hub.
Newer approaches / untapped opportunity areas are likely to emerge as key growth drivers in the long-term.
Notably, as specialty CROs further establish their service portfolios, it is believed that the market is likely to sustain the growth momentum in the coming years.
Example Players in the Specialty CROS Market
Accelovance
Almedis
Applied Healthcare Resource Management
Betagenex
Biospective
BRI Biopharmaceutical
BTS Research
Cardialysis
CMX Research
Crown Bioscience
Dorizoe Lifesciences
DSP Clinical Research
DZS Clinical Services
EthosExcel(TM)
Fluofarma
ICRC-Weyer
Impact Pharmaceutical Services
IonsGate Preclinical Services
KIYATEC
MedSource
Novella Clinical
Physiogenex
Profil Institute
Redoxis
RenaSci
Research Dynamics Consulting
RxGen
SDS Clinical
Spirovation
Velesco Pharmaceutical Services
SPECIALTY CROS MARKET: RESEARCH COVERAGE
Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the specialty CROs market, focusing on key market segments, including [A] target therapeutic area, [B] type of service and [E] key geographical regions.
Market Landscape: A comprehensive evaluation of specialty CROs, based on several relevant parameters, such as [A] geographical location, [B] year of establishment and [C] R&D capabilities.
Company Profiles: In-depth profiles of specialty CROs focused on specialized preclinical / clinical service offering and particular therapeutic area, based on [A] overview of the company, [B] service portfolio and [C] recent developments and an informed future outlook.
Case Study 1: A detailed discussion of the virtually integrated, cross-functional outsourcing approach implemented by virtual CROs.
Case study 2: A detailed discussion of the one-stop-shop approach followed by traditional CROs.
KEY QUESTIONS ANSWERED IN THIS REPORT
How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older
TABLE OF CONTENTS
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.2.1. Research Assumptions
1.2.2. Project Methodology
1.2.3. Forecast Methodology
1.2.4. Robust Quality Control
1.2.5. Key Considerations
1.2.5.1. Demographics
1.2.5.2. Economic Factors
1.2.5.3. Government Regulations
1.2.5.4. Supply Chain
1.2.5.5. COVID Impact / Related Factors
1.2.5.6. Market Access
1.2.5.7. Healthcare Policies
1.2.5.8. Industry Consolidation
1.3 Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. History
3.2. Traditional Contract Research Organizations
3.2.1. Services
3.2.2. Current Industry Environment
3.3. Specialty Contract Research Organizations
4. SPECIALTY CROs: AN INTRODUCTION
4.1. Chapter Overview
4.2. Importance of Specialty CROs
5. MARKET OVERVIEW
5.1. Chapter Overview
5.2. Methodology
5.3. Specialty CROs: Global Landscape
5.3.1. Specialty CROs: The Dramatic Rise
5.3.2. Specialty CROs: Distribution by Nature of Specialization
5.4. Specialty CROs Focused on Specific Service Capability
5.4.1. Landscape is Well Distributed across Preclinical and Clinical Services
5.4.2. Specialty CROs: Popular Preclinical Services
5.4.3. Specialty CROs: Popular Clinical Services
5.5. Specialty CROs Focused on Specific Therapeutic Area(s)
5.5.1. Oncology is the Most Researched Therapeutic Area
5.5.2. CROs Mostly Located in the US; Europe is a Distant Second
6. SPECIALTY CROs: FOCUSED ON SERVICES
6.1. Chapter Overview
6.2. CROs Focused on Preclinical Service Capabilities
6.2.1. BRI Biopharmaceutical Research
6.2.1.1. Company Overview
6.2.1.2. Focused Clinical Expertise
6.2.1.2.1. API / Clinical Product QC, Dosing Solutions & Materials
6.2.1.2.2. Bioanalytical Assays for Clinical Trials